A meta-analysis including 52 RCTs suggested that GLP-1RA did not increase the risk of breast cancer (RR 0.98) (Piccoli et al., 2021)
But depending on the individual, the most powerful reason might be cosmetic. The soaring demand for GLP-1s has created shortages across the country
These limitations have pushed researchers and athletes toward alternative strategies that separate muscle building from fat accumulation
Stopping treatment is a valid choice but it should be an informed one, made with a clear plan in place, not an impulsive decision made in response to a tough week." Aaliyah Mallard, PharmD For more on what sustainable long-term success looks like on GLP-1 treatment, read our guide on maintaining weight loss long-term, or learn about breaking through weight loss plateaus if you're considering stopping because results have stalled
A hybrid construct of decellularized matrix and fibrin for differentiating adipose stem cells into insulin-producing cells, an optimized in vitro assessment